Department
Neurology
TBI, Stroke, Dementia, Cognitive Enhancement
HBOT Applications
Mild Traumatic Brain Injury (mTBI)
B-level evidence from clinical trials demonstrating improvements in neurocognitive deficits, post-concussion symptoms, and brain microstructure in mTBI patients.
Protocol
Pressure
1.5 – 2.0 ATA
Duration
60 – 90 min
Sessions
40 – 60
Frequency
Once daily, 5×/week
Evidence basis: Level B Evidence
Stroke Recovery
Investigational adjunctive therapy for ischemic stroke recovery. HBOT promotes neuroplasticity, reduces peri-infarct hypoxia, and may improve functional outcomes.
Protocol
Pressure
2.0 ATA
Duration
90 min
Sessions
40 – 60
Frequency
Once daily, 5×/week
Evidence basis: Clinical Research
Vascular Dementia
HBOT reverses chronic cerebral hypoperfusion and promotes angiogenesis in brain tissue. Clinical studies show improvements in cognitive function in vascular dementia patients.
Protocol
Pressure
2.0 ATA
Duration
90 min
Sessions
60
Frequency
Once daily, 5×/week
Evidence basis: Clinical Research
Cognitive Enhancement in Healthy Aging
Randomized controlled trial demonstrated significant cognitive enhancements in healthy older adults, including memory and processing speed improvements correlated with increased cerebral blood flow.
Protocol
Pressure
2.0 ATA
Duration
90 min
Sessions
60
Frequency
Once daily, 5×/week
Evidence basis: RCT (Hadanny et al., 2020)
Neurodegenerative Diseases
Emerging preclinical and early clinical evidence for Alzheimer's disease and Parkinson's disease. HBOT reduces neuroinflammation and promotes neurogenesis.
Protocol
Pressure
2.0 ATA
Duration
90 min
Sessions
40 – 60
Frequency
Once daily, 5×/week
Evidence basis: Preclinical / Early Phase
Long COVID
Persistent cognitive dysfunction, brain fog, fatigue, sleep disturbance, and pain following SARS-CoV-2 infection. A randomised controlled trial reported significant improvements after 40 HBOT sessions, with benefits sustained at one-year follow-up. Evidence currently anchored to a single research group; independent replication ongoing.
Protocol
Pressure
2.0 ATA
Duration
90 min
Sessions
40
Frequency
5×/week
Evidence basis: RCT (Zilberman-Itskovich et al., 2022)
Fibromyalgia
Chronic central sensitisation syndrome with widespread pain, tender points, fatigue, sleep disturbance, and cognitive symptoms. A 2015 prospective controlled trial reported significant improvements after 40 HBOT sessions at 2.0 ATA, with two independent 2023 meta-analyses confirming improvements in function, tender points, fatigue, sleep, and quality of life across pooled randomised data.
Protocol
Pressure
2.0 ATA
Duration
90 min
Sessions
40
Frequency
5×/week
Evidence basis: Prospective Controlled Trial (Efrati et al., 2015)